Jane Mckeating

Jane Mckeating


Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2005 in Science
Verified
Journal Article
Closed access
PDF file
BLBrett D. Lindenbach
Brett D. Lindenbach
MEMatthew Evans
Matthew Evans
ASAndrew J. Syder
Andrew J. Syder
BWBenno WölK
Benno WölK
TTTimothy L. Tellinghuisen
Timothy L. Tellinghuisen
CRCharles M. Rice
Charles M. Rice
Many aspects of the hepatitis C virus (HCV) life cycle have not been reproduced in cell culture, which has slowed research progress on this important human pathogen. Here, we describe a full-length HCV genome that replicates and produces virus particles that are infectious in cell culture (HCVcc). Replication of HCVcc was robust, producing nearly 10 5 infectious units per milliliter within 48 hours. Virus particles were filterable and neutralized with a monoclonal antibody against the viral glycoprotein E2. Viral entry was dependent on cellular expression of a putative HCV receptor, CD81. HCVcc replication was inhibited by interferon-α and by several HCV-specific antiviral compounds, suggesting that this in vitro system will aid in the search for improved antivirals.

15 December 2002 in Journal of Virology
Verified
Journal Article
Open access
PDF file
KBKeril J. Blight
Keril J. Blight
JMJane Mckeating
Jane Mckeating
CRCharles Rice
Charles Rice
Hepatitis C virus (HCV) replication appears to be restricted to the human hepatoma cell line Huh-7, indicating that a favorable cellular environment exists within these cells. Although adaptive mutations in the HCV nonstructural proteins typically enhance the replicative capacity of subgenomic replicons in Huh-7 cells, replication can only be detected in a subpopulation of these cells. Here we show that self-replicating subgenomic RNA could be eliminated from Huh-7 clones by prolonged treatment with alpha interferon (IFN-α) and that a higher frequency of cured cells could support both subgenomic and full-length HCV replication. The increased permissiveness of one of the cured cell lines allowed us to readily detect HCV RNA and antigens early after RNA transfection, eliminating the need for selection of replication-positive cells. We also demonstrate that a single amino acid substitution in NS5A is sufficient for establishing HCV replication in a majority of cured cells and that the major phosphate acceptor site of subtype 1b NS5A is not essential for HCV replication.

25 February 2007 in Nature
Verified
Journal Article
Closed access
MEMatthew Evans
Matthew Evans
THThomas von Hahn
Thomas von Hahn
DTDonna M. Tscherne
Donna M. Tscherne
ASAndrew J. Syder
Andrew J. Syder
MPMaryline Panis
Maryline Panis
CRCharles Rice
Charles Rice

1 April 1999 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JGJanis V. Giorgi
Janis V. Giorgi
LHLance E. Hultin
Lance E. Hultin
JMJane Mckeating
Jane Mckeating
TJTimothy D. Johnson
Timothy D. Johnson
BOBronwyn Owens
Bronwyn Owens
RDRoger Detels
Roger Detels
To define predictors of survival time in late human immunodeficiency virus type 1 (HIV-1) disease, long- and short-duration survivors were studied af

24 April 2011 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JLJoachim Lupberger
Joachim Lupberger
MZMirjam B Zeisel
Mirjam B Zeisel
FXFei Xiao
Fei Xiao
CTChristine Thumann
Christine Thumann
IFIsabel Fofana
Isabel Fofana
TBThomas Baumert
Thomas Baumert

21 May 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MHMayla Hsu
Mayla Hsu
JZJie Zhang
Jie Zhang
MFMichael Flint
Michael Flint
CLCarine Logvinoff
Carine Logvinoff
CCCecilia Cheng-Mayer
Cecilia Cheng-Mayer
JMJane Mckeating
Jane Mckeating
HIV pseudotypes bearing native hepatitis C virus (HCV) glycoproteins (strain H and Con1) are infectious for the human hepatoma cell lines Huh-7 and PLC/PR5. Infectivity depends on coexpression of both E1 and E2 glycoproteins, is pH-dependent, and can be neutralized by mAbs mapping to amino acids 412–447 within E2. Cell-surface expression of one or all of the candidate receptor molecules (CD81, low-density lipoprotein receptor, scavenger receptor class B type 1, and dendritic cell-specific intercellular adhesion molecule 3 grabbing nonintegrin) failed to confer permissivity to HIV–HCV pseudotype infection. However, HIV–HCV pseudotype infectivity was inhibited by a recombinant soluble form of CD81 and a mAb specific for CD81, suggesting that CD81 may be a component of a receptor complex.